• Users Online: 324
  • Print this page
  • Email this page


 
 
Table of Contents
BASIC RESEARCH
Year : 2019  |  Volume : 9  |  Issue : 3  |  Page : 98-108

Phytochemical studies and anti-ulcerative colitis effect of Moringa oleifera seeds and Egyptian propolis methanol extracts in a rat model


1 Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt
2 Department of Parasitology & Animal Diseases, National Research Centre, 33 Bohouth St., Dokki, Giza, 12622, Egypt
3 Immunology Department, Theodor Bilharz Research Institute, Giza, 12411, Egypt
4 Department of Animal Reproduction and Artificial Insemination, National Research Centre, 33 Bohouth St., Dokki, 12622, Giza, Egypt

Date of Submission26-Dec-2018
Date of Decision30-Jan-2019
Date of Acceptance12-Mar-2019
Date of Web Publication25-Mar-2019

Correspondence Address:
Attia H Atta
Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza P.O. box 12211
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2221-1691.254603

Get Permissions

  Abstract 


Objective: To analyze the phytochemical constituents, and to explore potential protective effect of the methanol extract of Moringa oleifera (M. oleifera) seeds and Egyptian propolis, each alone or concurrently administered on acetic acid-induced ulcerative colitis in rats. Methods: Eight groups of 5 rats each were used: normal control group with distilled water, model group, two groups with M. oleifera seeds (100 and 200 mg/kg), two groups with propolis (50 and 100 mg/kg), one group with concurrent administration of both, and one group with prednisolone (reference drug). Macro-and microscopic picture, ulcer index and lesion scores, oxidative markers, inflammatory mediators, in vitro activity of the inflammatory enzymes and 1, 1-diphenyl-2-picrylhydrazyl free radicals scavenging activity were evaluated. The phytochemical constituents of both extracts were explored by GC-MS analysis. Results: Both treatments modulated the macro-and microscopic picture, decreased the ulcerative index, lesion score, oxidative markers and inflammatory mediators, and inhibited the COX-1 and COX-2 enzymes. Propolis appeared to be powerful free radicals scavenger. A powerful synergistic effect of both treatments in modulating the course of the disease was reported. GC-MS analysis of methanol extract of M. oleifera seeds and propolis revealed the presence of 50 and 34 compounds, respectively. Conclusions: M. oleifera seeds and propolis methanol extracts have modulated the course of acetic acid-induced ulcerative colitis. Moreover, both treatments induce a good synergistic effect against the disease. Isolation of the active constituents is recommended.

Keywords: Moringa oleifera seeds, Propolis, Ulcerative colitis, Phytochemical


How to cite this article:
Atta AH, Mouneir SM, Nasr SM, Sedky D, Mohamed AM, Atta SA, Desouky HM. Phytochemical studies and anti-ulcerative colitis effect of Moringa oleifera seeds and Egyptian propolis methanol extracts in a rat model. Asian Pac J Trop Biomed 2019;9:98-108

How to cite this URL:
Atta AH, Mouneir SM, Nasr SM, Sedky D, Mohamed AM, Atta SA, Desouky HM. Phytochemical studies and anti-ulcerative colitis effect of Moringa oleifera seeds and Egyptian propolis methanol extracts in a rat model. Asian Pac J Trop Biomed [serial online] 2019 [cited 2019 Jun 24];9:98-108. Available from: http://www.apjtb.org/text.asp?2019/9/3/98/254603




  1. Introduction Top


Ulcerative colitis (UC) is a common chronic inflammatory disease of the large intestine with unknown etiology[1]. It is characterized by erosions of the colon and rectal mucosa with the development of tiny open sores or ulcers, with no segments of normal tissue[2]. Increases in certain inflammatory mediators and appearance of signs of oxidative stress are among the pathological findings associated with UC[3]. The aim of treatment of UC is to maintain remission, reduce complications and improve quality of life. Important therapeutic achievement was obtained >15 years ago by the introduction of biological therapies such as the anti-tumor necrosis factor alpha (anti-TNF-α) and monoclonal antibodies[4]. However, the high cost of biological drugs and their patent expiration limit their use[5]. In addition, the use of immunosuppressive treatment especially steroids is risky particularly in patients with viral hepatitis and/or bacterial infections[6]. Therefore, there is a growing need for effective and safe therapeutic agents for the treatment of UC. Alternative therapy for many diseases depends on natural products. Moringa oleifera Lam. (M. oleifera) grown in India, Pakistan, Bangladesh and Afghanistan[7] and introduced to Mediterranean region, is one of the promising plants because it contains several compounds that have antioxidant (ascorbic acid, carotenoids, flavonoids, and phenols), anti-inflammatory (isothiocianate and phenolic derivatives)[8] and immunomodulatory[9] effects. M. oleifera has been used traditionally for the treatment of many diseases[10]. The root-bark extract[11] and leaves[12] of M. oleifera have been shown to induce the antiulcerogenic effect. Data on the effect of methanol extract of M. oleifera seeds on UC is lacking. On the other hand, propolis (beeswax) is a mixture containing different compounds such as flavonoids, phenolic, amino acids and trace elements[13]. Propolis has a number of pharmacological effects such as antimicrobial, anti-inflammatory, antiparasitic, antitumor, and antioxidant[14]. Brazilian red propolis extract exerts protective effects on 2, 4, 6-trinitrobenzenesulfonic acid- and acetic acid-induced colitis in mice and rats[15]. Data on tissue-regenerating actions of propolis are incomplete and often contradictory[16]. This variation or contradiction in its biological activity could be explained on the bases of variation between cultivars from different geographical locations as it has been reported for propolis[17], for M. oleifera[18], and for other medicinal plants[19],[20]. This study aimed to analyze the phytochemical constituents, investigate the protective effect of methanol extract of M. oleifera seeds and Egyptian propolis on acetic acid-induced colitis in rats and to explore the potential synergistic effect of both extracts in minimizing the symptoms of colitis.


  2. Materials and methods Top


This experiment was carried out according to the guidelines of the Institutional Animal Care and Use Committee, National Research Centre, Approval Protocol No.: 18/103.

2.1. Plant material

Seeds of M. oleifera were donated from the Egyptian Scientific Society of Moringa, National Research Centre, Dokki, Giza, Egypt. Seeds were air dried and moderately pulverized. The powdered plant seeds (200 g) were extracted by percolation for 24 h in methanol 95% several times. The solvent was then evaporated under reduced pressure using a rotary evaporator at a low temperature not more than 50 °C. The yield was 35.7 g. The obtained extract was then kept at -4 °C until used. At the start of the experiments, the extract was freshly suspended in distilled water with few drops of Tween-80. Propolis was obtained from apiaries located in the Delta region, Egypt. Propolis was extracted with methanol several times and methanol was then evaporated at low temperature. The condensed propolis methanol extract was freshly suspended in 1% carboxymethyl cellulose.

2.2. Animals and grouping

Forty Sprague Dawley male and female rats (190-200 g) of six weeks age were used. Animals were allocated randomly into 8 equal groups (G I -G VIII). Rats of G I, as normal control, received an equal volume of distilled water. Rats of G II, as ulcerative colitis control, received an equal volume of distilled water before acetic acid-induction of ulcerative colitis. Rats of G III and G IV were pretreated orally with M. oleifera seeds methanol extract (MOSME) at a dose of 100 and 200 mg/ kg, respectively. Rats of G V and G VI were pretreated with propolis methanol extract orally at a dose of 50 and 100 mg/kg, respectively. Rats of G VII received propolis (50 mg/kg) and MOSME (100 mg/kg) orally. On the 8th day, rats of G II to G VII were administered 2 mL of acetic acid 4% solution intrarectally. Administration of M. oleifera and propolis continued till the 11th day. Rats of G VIII were treated with prednisolone (reference drug, 2 mg/kg, p.o., for 3 d) and acetic acid (2 mL of 4% solution, once, intrarectally) on the same day. Rats were kept in good hygienic conditions at room temperature of (25±3) C with a 12 h dark/light cycle. They were fed standard laboratory feed and watered ad libitum.

2.3. Sampling

Blood samples were withdrawn by retro-orbital puncture on the 11th day under light anesthesia. Serum was obtained by centrifugation of clotted blood. Animals were euthanized by an overdose of inhalation anesthesia. Colon of each rat, about 2 cm proximal to the anus and 8 cm in length, was taken out of the body and incised longitudinally, washed with normal saline and then placed on a transparent sheet and a photo was taken using an adjusted camera. Colons were then examined macro- and microscopically. Specimens of colon were fixed in 10% formol saline solution for histopathological studies. Samples from the colon were stored immediately at -80 °C till biochemical analysis.

2.4. Evaluation of colon macroscopic damage

Lesions of the colon were evaluated macroscopically according to the grading scale of Morris et al.[21]. The scores were 0=no macroscopic changes, 1= mucosal erythema only, 2= mild mucosal edema, slight bleeding, or slight erosion, 3= moderate edema, bleeding ulcers, or erosions, and 4= severe ulceration, erosions, edema, and tissue necrosis.

2.5. Determination of ulcer index (UI)

The sum of the total length of long ulcers and petechial lesions in each group of rats was divided by its number to calculate the UI (mm)[22].

2.6. Biochemical assays

2.6.1. Determination of colonic TNF- α level

Frozen (-80 °C) colon tissue samples were immediately weighed, minced on an ice-cold plate and maintained in a tube with 10 mmol/L sodium phosphate buffer (pH 7.4) (1:5 w/v). The tubes were shaken in a shaking water bath (37 °C) for 20 min and centrifuged at 9000 × g for 10 min at 4 °C ; the supernatant was frozen at -80 °C until assay. TNF- α was quantified in the homogenate samples of colons by enzyme-linked immunosorbent assay (ELISA) and the results were expressed as pg/g of wet tissue.

2.6.2. Determination of colonic malondialdehyde (MDA) contents

Colonic MDA level was determined in tissue homogenates by the reaction with thiobarbituric acid as described by Ohkawa et al.[23] using commercial kits from Biodiagnostic Co., Egypt. The values were expressed as nmol MDA/g protein.

2.6.3. Determination of colonic myeloperoxidase (MPO) contents

The activity of MPO is defined as the quantity of enzyme degrading 1 μmol of peroxide per min at 25 °C and is expressed in U/g of wet scrapings. The colonic MPO activity was determined according to Krawisz et al.[24].

2.6.4. Determination of colonic nitrite/nitrate level

Nitric oxide (NO) level in the colon samples was determined by the acidic Griess reaction after reduction of nitrate to nitrite by vanadium trichloride as described by Miranda et al.[25]. A pink azo-product is produced as a result of the reaction between nitrite, sulfonamide, and N-(1-naphthyl) ethylenediamine. The intensity of the color was then measured at a maximum absorbance of 543 nm. A standard curve of sodium nitrate was established and the concentrations were expressed as μg/mg of wet tissue.

2.6.5. In vitro effect on the inflammatory enzymes (COX-1 and COX-2)

The ability of M. oleifera and propolis to inhibit COX-1 and COX-2 was evaluated using an ovine COX-1/COX-2 inhibitor screening assay kit (catalog no. 760111, Cayman Chemicals, MI, USA) that utilizes the peroxidase component of COX. The peroxidase activity is assayed colorimetrically by monitoring the appearance of oxidized N,N,N',N'-tetramethyl-1,4-phenylenediamine according to Kulmacz and Lands[26]. In addition, the selectivity index (SI values) for the tested compounds was calculated as IC50 (COX-1)/IC50 (COX-2). Celecoxib was used as a reference COX-2 inhibitor.

2.7. Determination of in vitro antioxidant effect

The antioxidant activities of MOSME and propolis methanol extract were tested in vitro by free radical scavenging assay method described by Sreelatha and Padma[27] using 1, 1-diphenyl-2-picrylhydrazyl (DPPH).

2.8. Histopathological evaluation

Colon samples were washed off formol saline with tap water and dehydrated with serial dilutions of ethanol. Specimens were cleared in xylene and embedded in paraffin at 56 °C in a hot air oven for 24 h. Paraffin tissue blocks were sectioned at 5 microns thickness by slide microtome. The obtained tissue sections were mounted on glass slides, deparaffinized and stained by hematoxylin & eosin (H&E) and examined under light microscope[28]. Inflammatory changes, necrotic foci, and damage to tissue structures or to the nucleus in the stained sections were recorded.

2.9. GC-MS analysis

Gas chromatograph (GC, Agilent Technologies 7890A) interfaced with a mass-selective detector (Agilent 7000 Triple Quad) was used. Agilent HP-5ms capillary column (30 m×0.25 mm ID and 0.25 μm film thicknesses) was used. The flow rate was 1 mL/min. The injector and detector temperatures were 200 °C and 250 °C , respectively. The acquisition mass range was 50-600. The chemical structure of the compounds was identified and recorded after comparing their mass spectra and retention time (RT) with those of NIST and WILEY library.

2.10. Statistical analysis

Data were presented as mean±SD. Differences between means were tested for significance by ANOVA test using SPSS version 16 computer program. Probability level of P<0.05 was taken as indication of significance.


  3. Results Top


3.1. Effect on the macroscopic picture

Acetic acid produced severe colonic damage characterized by inflammation, swelling, edema, hemorrhages, and necrosis. Dose-dependent mild to moderate inflammatory changes appeared in the colon of rats treated with either MOSME or propolis methanol extract. Concurrent administration of both MOSME and propolis methanol extract completely protected colonic mucosa against acetic acid-induced changes [Figure 1]a,[Figure 1]b,[Figure 1]c,[Figure 1]d,[Figure 1]e,[Figure 1]f,[Figure 1]g,[Figure 1]h.
Figure 1: Macroscopic pictures of colon.
(a) normal rat, (b) rats with experimental ulcerative colitis (UC), (c and d) rat with UC treated with MOSME (100 and 200 mg/kg, respectively), (e and f) rat with UC treated with propolis (50 and 100 mg/kg, respectively), (g) rat with UC concurrently treated with MOSME, 100 mg/kg and propolis, 50 mg/kg, and (h) rat treated with prednisolone 2 mg/kg.


Click here to view


3.2. Effect on the UI

Administration of acetic acid dramatically increased the UI (438.17 ± 59.26) as compared to that of normal rats (3.53 ± 0.60). Administration of MOSME induced a dose-dependent significant (P<0.05) decrease in the UI. The lesion scores were also dramatically increased by acetic acid and decreased by pretreatment with MOSME or propolis. Concurrent administration of both MOSME and propolis methanol extract significantly decreased the UI (P<0.05) and lesion scores to values nearly similar to the normal control or to prednisolone. The percent inhibition of colonic damage in rats concurrently pretreated with MOSME and propolis was nearly similar to that pretreated with prednisolone [Table 1].
Table 1: Effect of methanol extract of M. oleifera seeds and Egyptian propolis on UI and lesion scores in rats with UC (Mean ± SD, n=5).

Click here to view


3.3. Effect on the inflammatory mediators and oxidative markers

Rectal administration of acetic acid significantly increased the inflammatory mediators (TNF- α and NO) and the oxidative markers (MPO and MDA) levels in colonic tissue of treated rats as compared to normal one. Administration of MOSME or propolis methanol extract induced a dose-dependently significant (P<0.05) decrease in both the inflammatory mediators and the oxidative markers. Concurrent administration of both MOSME and propolis methanol extract significantly decreased the levels of the inflammatory mediators and the oxidative markers which were comparable to normal control and prednisolone [Table 2].
Table 2: Effect of methanol extract of M. oleifera seeds and Egyptian propolis on the oxidative markers and the inflammatory mediators in rats with UC (Mean ± SD, n=5).

Click here to view


3.4. In vitro effect on COX-1 and COX-2

The present results showed that both MOSME and propolis methanol extract are potential inhibitors to the inflammatory enzymes; COX-1 and COX-2. The high selectivity for COX-1 inhibition was recorded for the MOSME followed by propolis and then celecoxib (reference COX-2 inhibitor). In contrast, the high selectivity for COX-2 inhibition was recorded for the celecoxib (SI: 302) followed by propolis and then MOSME [Table 3].
Table 3: In vitro COX-1, COX-2 anti-inflammatory activities of M. oleifera seeds and Egyptian propolis methanol extracts.

Click here to view


3.5. In vitro antioxidant effect

Scavenging activity of MOSME against DPPH was weak with only 6.2% scavenging level at 100 μg/mL of the extract. However, propolis methanol extract had high activity against DPPH with an IC50 value of 10.34 μg/mL and 92.5% scavenging rate of free radicals at the same concentration.

3.6. Effect on the histopathological picture

Microscopic examination of colons sections of normal rats showed a normal histological structure of the mucosa, glandular structure with activation of goblet cells, submucosa and muscularis and serosa [Figure 2]a. Colon of rats with experimental UC showed focal ulceration, hemorrhages and necrosis with inflammatory cells infiltration in the mucosa, submucosa, muscularis and serosa of the colon wall [Figure 2]b. Colon of rats with UC treated with MOSME at a dose of 100 mg/kg showed less focal ulceration and necrosis with hemorrhage and inflammatory cells infiltration in the mucosa, submucosa and muscularis [Figure 2]c. Colon of rats with UC treated with MOSME at a dose of 200 mg/kg showed moderate focal ulceration and necrosis associated with inflammatory cells infiltration and mild hemorrhages in the submucosa, muscularis and serosa [Figure 2]d. Colon of rats with UC treated with propolis methanol extract at a dose of 50 mg/kg showed focal ulceration and necrosis in the mucosa and inflammatory cells infiltration and hemorrhages in the submucosa [Figure 2]e. Colon of rats with UC treated with propolis methanol extract at a dose of 100 mg/kg showed mild focal ulceration and necrosis in the mucosa associated with inflammatory cells infiltration [Figure 2]f. Colon of rats with UC and treated with both MOSME (100 mg/kg) and propolis extract 50 mg/kg [Figure 2]g as well as those treated with prednisolone in a dose of 2 mg/kg [Figure 2]h showed intact mucosa with inflammatory cells infiltration in the underlying submucosa.
Figure 2:g Histopathological pictures of colon sections.
(a) normal rat, (b) rats with experimental ulcerative colitis (UC), (c and d) rat with UC treated with MOSME (100 and 200 mg/kg, respectively), (e and f) rat with UC treated with propolis (50 and 100 mg/kg, respectively), (g) rat with UC treated with MOSME (100 mg/kg) and propolis (50 mg/kg) and (h) rat treated with prednisolone (2 mg/kg) (H&E, ×100).


Click here to view


3.7. GC-MS analysis of the methanol extract

GC-MS analysis revealed the presence of 50 and 34 compounds in MOSME and propolis extract respectively [Table 4] & [Table 5] and [Figure 3]. There were 34 and 17 compounds of more than 1% in MOSME and propolis extract, respectively. The major components are 2,5-Di-tert-butyl-1,4-benzoquinone (15.43%) and 4',6-dimethoxyisoflavone-7-O-β -D-glucopyranoside (9.25%) in MOSME and fraxidin (30.15%), methyl a -D-rhamnopyranoside (17.28%) and 6-ethyl-3-formylchromone (5.24%) in propolis extract.
Table 4: GC-MS analysis of MOSME.

Click here to view
Table 5: GC-MS analysis of Egyptian propolis methanol extract.

Click here to view
Figure 3: GC-MS peaks of (a) MOSME and (b) Egyptian propolis methanol extract.

Click here to view



  4. Discussion Top


In this work, an acetic acid model of experimental colitis in rats was used as it has been reported that acetic acid produces rapid and reproducible colitis suitable for screening of drugs for anti-colitis effects[29]. In this study, acetic acid induced severe colonic damage and the macroscopic lesions characterized by inflammation, swelling, edema, hemorrhages, and necrosis. It also increased colonic major inflammatory mediators in similar patterns to inflammatory bowel disease (IBD). TNF- α is one of the cytokines that are involved in systemic inflammation and make up the acute phase reaction. It is produced by activated lymphocytes, macrophages, neutrophils, mast cells, eosinophils, and neurons[30] and can be released as a result of an inflammatory stimulus (e.g. lipopolysaccharide)[31]. MDA is a product of degradation by reactive oxygen species of polyunsaturated lipids[32]. It is a reactive aldehyde that causes toxic effects in the cells[33]. Its level is used as an indicator of the degree of oxidative stress in an organism[34]. MPO is an important enzyme released by activated polymorphonuclear neutrophils during phagocytic lysis of engulfed foreign particles. It activates the synthesis of hypochlorous acid from hydrogen peroxide and chloride anion[35],[36]. Hypochlorous acid radicals are cytotoxic to bacteria and other pathogens[37]. However, it may also cause oxidative damage in host tissue. Its increased level is considered as a biomarker of inflammation[38]. NO is a free radical associated with fatty liver disease and is involved in hepatic lipid metabolism under starvation[39]. Pro-inflammatory mediators, such as cytokines and NO are released by inflammatory cells massively infiltrating the inflamed intestine of patients with IBD[40]. In this study, acetic acid produced a dramatic increase in TNF- α, NO, MDA, and MPO which are evident in IBD disease[8]. The decreased pro-inflammatory mediators and improvement of macro- and microscopic picture reported in this study could confirm the strong antioxidant and anti- inflammatory effect of both M. oleifera and propolis[8],[14]. The acetic acid-induced tissue damage was suggested to be ameliorated by antioxidants that inhibit the enzymes and/or chelating trace elements involved in the free-radical production. The decrease in the MDA and NO level in the MOSME and propolis extract indicates the role of the extracts as antioxidants. It has been previously reported that the protective effect against acetic acid-induced damage includes scavenging reactive species, protecting antioxidant defenses, and activating antioxidant enzymes[41]. The protective effects of MOSME are also probably due to its anti-inflammatory. Other mechanisms for the antioxidant effect of M. oleifera have been reported such as superoxide anion and NO radical scavenging activity that prevents oxidative damage of major biomolecules[26],[42]. In this study, propolis has been proved to induce a strong in vitro DPPH free radicle scavenging activity, providing its antioxidant activity. The antioxidant activity is usually attributed to the total phenolics and flavonoids[43]. M. oleifera seeds extract was shown to have significant antioxidant effect which was attributed to its phenolic content[44]. Other bioactive constituents from M. oleifera such as glucosinolates, isothiocyanates, and thiocarbamates were suggested to be responsible for antioxidant effect[45]. Isothiocyanates have been proved to have anti-inflammatory as well as immunomodulatory activities[8] to which the anti-ulcerative effect was attributed[9],[46]. Moreover, the antioxidant properties of M. oleifera were suggested to be mediated through direct trapping of the free radicals and also through metal chelation which was attributed to the presence of phenolic acids and flavonoids[47]. It has been reported that flavonoids possess potent antioxidant effect[48]. In this study, the GC-MS analysis of the methanol extract of M. oleifera seeds revealed the presence of at least 10 flavonoid flavones namely, 5, 7, 3',4',5'-pentamethoxyflavone (1), 3, 7, 3',4',5'-pentahydroxyflavone (2), 3',4'-dihydroxy- β -naphthoflavone (3), 5, 7, 3',4'-tetramethoxyflavone (4), 5, 7, 3',4',5'- pentahydroxyflavone (5), 4',6-dimethoxyisoflavone-7-O- β -D-glucopyranoside (6), 7,4'-dimethoxy-3-hydroxyflavone (7), 6,4'- dimethoxy-7-hydroxyisoflavone (8), 3, 6, 2',3'-tetrahydroxyflavone (9), 5,3'-dihydroxy-6, 7, 4'-trimethoxyflavone (10). The flavonoid flavones may be contributed to the antioxidant effect of MOSME. Moreover, the phytochemical analysis in the present study revealed that MOSME contains the essential oil alloaromadendrene which has been previously reported to have an antioxidant effect[49]. More recently, phytochemical analysis of MOSME revealed the presence of isovitexin which has been reported to be responsible for inhibition of TNF- α level, MPO activity and MDA content as it occurs in animals with liver intoxication[50]. In this study, the antioxidant effect is also confirmed in vitro by the high scavenging activity against DPPH free radicals. This antioxidant effect is nearly similar to that previously reported for Moringa peregrina[51],[52] and M. oleifera[53] extracts. On the other hand, phytochemical analysis of propolis revealed the presence of at least 9 flavonoid flavones namely; 3,3', 7, 8-tetramethoxyflavone (1), 5, 7, 3',4',5'-pentahydroxyflavone (2), 4',6-dimethoxyisoflavone-7-O- β -D-glucopyranoside (3), 7-hydroxy-6-methoxyisoflavone (4), 7, 8, 3',4'-tetrahydroxyflavone (5), 3-hydroxy-6,2',4'-trimethoxyflavone (6), 4'-benzyloxy-5,7- dimethoxyflavone (7), 4'-hydroxyflavanone (8) and 3,2',4',5'- tetramethoxyflavone (9). These flavones may also be contributed to the antioxidant effect of propolis. It should be pointed out that MOSME and propolis methanol extract have common compounds with an identical structural formula such as 5, 7, 3',4',5'- pentahydroxyflavone and 4',6-dimethoxyisoflavone-7-O- β -D-glucopyranoside which could explain the synergistic antioxidant effect between them. Moreover, the methanol extract of both M. oleifera and propolis in this work showed a potent inhibitory effect on the inflammatory enzymes (COX-1 and COX-2). However, a high selectivity index was recorded for the celecoxib followed by propolis and then MOSME proving a selective inhibition of COX-2, which plays a key role in prostaglandin biosynthesis and hence protects colonic mucosa against acetic acid-induced damage. Moreover, M. oleifera flower hydroethanolic extract was reported to suppress the secretion of NO, prostaglandin E2, TNF- α, inducible NO synthase, and COX-2[54]. M. oleifera has also been reported to have a suppressive effect on COX-1[55].

On the other hand, the extract of M. oleifera and propolis suppresses leukotriene biosynthesis (TNF- α); a mechanism which is similar to glucocorticoids anti-inflammatory effect in relieving human IBD[56]. Additional mechanisms such as improvement of cellular and humoral immunity by M. oleifera[57] and by propolis[58] can also be involved in the protective effect against acetic acid-induced colitis. Furthermore, M. oleifera contains β -caryophyllene which has been shown to have anti-inflammatory and anti-edematogenic action[59]. Moreover, propolis contains abundant polyphenolic compounds[60] which were claimed to exhibit significant anti-inflammatory effects, probably by blocking the activation of inflammatory mediator NF-κB[61],[62]. In this study, propolis has been also proved to inhibit the inflammatory mediators; TNF- α and NO. The synergistic effect between MOSME and propolis was marked in inhibition of these mediators. The synergistic effect of MOSME and propolis was also marked in an improvement of the histopathological picture of livers of treated rats as compared to those treated by each one alone. The outcome of the combined treatment with M. oleifera seeds and propolis extracts was better than the use of each one alone or even the use of prednisolone regarding the inflammatory mediators (TNF- α, NO), and the oxidative markers (MDA, MPO) as well as the macro and microscopic picture confirming a synergistic effect of both M. oleifera and propolis.

Our findings suggest a useful therapeutic activity for the methanol extract of M. oleifera seeds and of propolis as an anti-ulcerative remedy. A synergistic effect between MOSME and propolis was pronounced suggesting their possible use as an alternative therapy for the colonic inflammatory condition.

Conflict of interest statement

The authors declare that there is no conflict of interest.



 
  References Top

1.
Romana BS, Albarrak AA, Yousef MH, Tahan V. Infliximab use in ulcerative colitis flare with clostridium difficile infection: A report of two cases and literature review. North Clin Istanb 2018; 5(3): 256-260. Doi: 10.14744/nci.2017.79446  Back to cited text no. 1
    
2.
Fukuda T, Naganuma M, Kanai T. Current new challenges in the management of ulcerative colitis. Intest Res 2019; 17(1): 36-44. Doi: 10.5217/ir.2018.00126.  Back to cited text no. 2
    
3.
Kumar VL, Pandey A, Verma S, Das P. Protection afforded by methanol extract of Calotropis procera latex in experimental model of colitis is mediated through inhibition of oxidative stress and pro-inflammatory signaling. Biomed Pharmacother 2019; 109: 1602-1609. Doi: 10.1016/ j.biopha.2018.  Back to cited text no. 3
    
4.
Deleporte A, Viennot S, Dupont B, Giletta C, Allaire M, Prévost F, et al. Efficacy of anti-TNF-alpha monoclonal antibodies in inflammatory bowel disease treatment. Int J Interferon Cytokine Mediat Res 2013; 2013(5): 11-31. Doi: 10.2147/IJICMR.S21705.  Back to cited text no. 4
    
5.
Bilsborough J, Targan SR, Snapper SB. Therapeutic targets in inflammatory bowel disease: Current and future. Am J Gastroenterol Suppl 2016; 3: 27-37. Doi: 10.1038/ajgsup.2016.18.  Back to cited text no. 5
    
6.
Stucker F, Ackermann D. Immunosuppressive drugs-how they work, their side effects and interactions. Ther Umsch 2011; 68(12): 679-686. Doi: 10.1024/0040-5930/a000230.  Back to cited text no. 6
    
7.
Padayachee B, Baijnath H. An overview of the medicinal importance of Moringaceae. J Med Plants Res 2012; 6(48): 5831-5839. Doi: 10.5897/ JMPR12.1187.  Back to cited text no. 7
    
8.
Mahajan SG, Mali RG, Mehta AA. Effect of Moringa oleifera Lam. seed extract on toluene diisocyanate-induced immune-mediated inflammatory responses in rats. J Immunotoxicol 2007; 4(2): 85-96. Doi:10.1080/15476910701337472.  Back to cited text no. 8
    
9.
Coriolano MC, de Santana Brito J, de Siqueira Patriota LL, de Araujo Soares AK, Lorena VMB, Paiva PMG, et al. Immunomodulatory effects of the water-soluble lectin from Moringa oleifera seeds (WSMoL) on human peripheral blood mononuclear cells (PBMC). Protein Pept lett 2018; 25(3): 295-301. Doi: 10.2174/0929866525666180130141736.  Back to cited text no. 9
    
10.
Stohs SJ, Hartman MJ. Review of the safety and efficacy of Moringa oleifera. Phytother Res 2015; 29(6): 796-804. Doi: 10.1002/ptr.5325.  Back to cited text no. 10
    
11.
Choudhary MK, Bodakhe SH, Gupta SK. Assessment of the antiulcer potential of Moringa oleifera root-bark extract in rats. J Acupunct Meridian Stud 2013; 6(4): 214-220. Doi: 10.1016/j.jams.2013.07.003.  Back to cited text no. 11
    
12.
Ijioma SN, Nwaogazi EN, Nwankwo AA, Oshilonya H, Ekeleme CM, Oshilonya LU. Histological exhibition of the gastroprotective effect of Moringa oleifera leaf extract. Comp Clin Pathol 2018; 27(2): 327-332. Doi: 10.1007/s00580-017-2594-0.  Back to cited text no. 12
    
13.
Machado BA, Silva RP, Barreto Gde A, Costa SS, Silva DF, Brandão HN, et al. Chemical composition and biological activity of extracts obtained by supercritical extraction and ethanolic extraction of brown, green and red propolis derived from different geographic regions in Brazil. PLoS One 2016; 11(1): e0145954. Doi: 10.1371/journal.pone.0145954.  Back to cited text no. 13
    
14.
de Freitas MCD, de Miranda MB, de Oliveira DT, Vieira-Filho SA, Caligiorne RB, de Figueiredo SM. Biological activities of red propolis: A review. Recent Pat Endocr Metab Immune Drug Discov 2017; 11(1): 3-12. Doi: 10.2174/1872214812666180223120316.  Back to cited text no. 14
    
15.
Barbosa Bezerra GB, de Menezes de Souza L, Dos Santos AS, de Almeida GK, Souza MT, Santos SL, et al. Hydroalcoholic extract of Brazilian red propolis exerts protective effects on acetic acid-induced ulcerative colitis in a rodent model. Biomed Pharmacother 2017; 85: 687-696. Doi:10.1016/j.biopha.2016.11.080.  Back to cited text no. 15
    
16.
Paulino N, Dantas AP, Bankova V, Longhi DT, Scremin A, de Castro SL, et al. Bulgarian propolis induces analgesic and anti-inflammatory effects in mice and inhibits in vitro contraction of airway smooth muscle. J Pharmacol Sci 2003; 93(3): 307-313.  Back to cited text no. 16
    
17.
Zancanela DC, Funari CS, Herculano RD, Mello VM, Rodrigues CM, Borges FA, et al. Natural rubber latex membranes incorporated with three different types of propolis: Physical-chemistry and antimicrobial behaviours. Mater Sci Eng C Mater Biol Appl 2019; 97: 576-582. Doi: 10.1016/j.msec.2018.12.042.  Back to cited text no. 17
    
18.
Iqbal S, Bhanger MI. Effect of season and production location on antioxidant activity of Moringa oleifera leaves grown in Pakistan. J Food Compost Anal 2006; 19(6-7): 544-551. Doi: 10.1016/j.jfca.2005.05.001.  Back to cited text no. 18
    
19.
Kasai H, Kubota Y. Analyses of volatile components of lavender (Lavandula angustifolia HIDCOTE and Lavandula xintermedia GROSSO) as influenced by cultivar type, part, and growth season. Yakugaku Zasshi 2018; 138(12): 1569-1577. Doi: 10.1248/yakushi.18-00159.  Back to cited text no. 19
    
20.
Škrovánková S, Mišurcová L, Machů L. Antioxidant activity and protecting health effects of common medicinal plants. Adv Food Nutr Res 2012; 67: 75-139. Doi: 10.1016/B978-0-12-394598-3.00003-4.  Back to cited text no. 20
    
21.
Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96(3): 795-803.  Back to cited text no. 21
    
22.
Ku SK, Seo BI, Park JH, Park GY, Seo YB, Kim JS, et al. Effect of Lonicerae Flos extracts on reflux esophagitis with antioxidant activity. World J Gastroenterol 2009; 15(38): 4799-4805.  Back to cited text no. 22
    
23.
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95(2): 351-258.  Back to cited text no. 23
    
24.
Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87(6): 1344-1350.  Back to cited text no. 24
    
25.
Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001; 5(1): 62-71.  Back to cited text no. 25
    
26.
Kulmacz RJ, Lands WE. Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase. Prostaglandins 1983; 25(4): 531-540.  Back to cited text no. 26
    
27.
Sreelatha S, Padma P. Antioxidant activity and total phenolic content of Moringa oleifera leaves in two stages of maturity. Plant Foods Hum Nutr 2009; 64(4): 303-311. Doi: 10.1007/s11130-009-0141-0.  Back to cited text no. 27
    
28.
Suvarna KS, Layton C, Bancroft JD. Bancroft's theory and practice of histological techniques e. Book [Online]. 7th ed. Churchill Livingstone: Elsevier Health Sciences; 2012. Available from: https://books.google. com.eg/books?id=wPPU4NyGm3gC&printsec=frontcover&source=g bs_ge_summary_r&cad=0#v=onepage&q&f=false [Accessed on 1 Oct 2012].  Back to cited text no. 28
    
29.
MacPherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion 1978; 17(2): 135-150.  Back to cited text no. 29
    
30.
Gahring LC, Carlson NG, Kulmer RA, Rogers SW. Neuronal expression of tumor necrosis factor alpha in the OVOUJI fme brain. Neuroimmunomodulation 1996; 3(5): 289-303. Doi: 10.1159/000097283.  Back to cited text no. 30
    
31.
Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991; 88(10): 4220-4224.  Back to cited text no. 31
    
32.
Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014; 2014: 360438. Doi: 10.1155/2014/360438.  Back to cited text no. 32
    
33.
Farmer EE, Davoine C. Reactive electrophile species. Curr Opin Plant Biol 2007; 10(4): 380-386.  Back to cited text no. 33
    
34.
Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 15(4): 316-328.  Back to cited text no. 34
    
35.
Heinecke JW, Li W, Francis GA, Goldstein JA. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest 1993; 91(6): 2866-2872.  Back to cited text no. 35
    
36.
Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing. Blood 1998; 92(9): 3007-3017.  Back to cited text no. 36
    
37.
Klebanoff SJ. Myeloperoxidase. Proc Assoc Am Physicians 1999; 111(5): 383-389.  Back to cited text no. 37
    
38.
Loria V, Dato I, Graziani F, Biasucci LM. Myeloperoxidase: A new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm 2008; 2008: 135625. Doi: 10.1155/2008/135625.  Back to cited text no. 38
    
39.
van Faassen EE, Bahrami S, Feelisch M, Hogg N, Kelm M, Kim-Shapiro DB, et al. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev 2009; 29(5): 683-741. Doi: 10.1002/med.20151.  Back to cited text no. 39
    
40.
Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011; 140(6): 1729-1737.  Back to cited text no. 40
    
41.
Montoro P, Braca A, Pizza C, De Tommasi N. Structure-antioxidant activity relationships of flavonoids isolated from different plant species. Food Chem 2005; 92(2): 349-355. Doi: 10.1016/j.foodchem.2004.07.028.  Back to cited text no. 41
    
42.
Luqman S, Srivastava S, Kumar R, Maurya AK, Chanda D. Experimental assessment of Moringa oleifera leaf and fruit for its antistress, antioxidant, and scavenging potential using in vitro and in vivo assays. Evid Based Complement Alternat Med 2012; 2012: 519084. Doi: 10.1155/2012/519084.  Back to cited text no. 42
    
43.
Pakade V, Cukrowska E, Chimuka L. Comparison of antioxidant activity of Moringa oleifera and selected vegetables in South Africa. S Afr J Sci 2013; 109(3/4): 1-5. Doi: 10.1590/ sajs.2013/1154.  Back to cited text no. 43
    
44.
Adebayo IA, Arsad H, Samian MR. Total phenolics, total flavonoids, antioxidant capacities, and volatile compounds gas chromatographymass spectrometry profiling of Moringa oleifera ripe seed polar fractions. Pharmacogn Mag 2018; 14(54): 191-194. Doi: 10.4103/pm.pm_212_17.  Back to cited text no. 44
    
45.
Kumar GS, Kumar B, Srinivasan BP, Nag TC, Srivastava S, Saxena R, et al. Retinoprotective effects of Moringa oleifera via antioxidant, anti-inflammatory, and anti-angiogenic mechanisms in streptozotocin-induced diabetic rats. J Ocul Pharmacol Ther 2013; 29(4): 419-426. Doi: 10.1089/ jop.2012.0089.  Back to cited text no. 45
    
46.
Kim Y, Wu AG, Jaja-Chimedza A, Graf BL, Waterman C, Verzi MP, et al. Isothiocyanate-enriched moringa seed extract alleviates ulcerative colitis symptoms in mice. PLoS One 2017; 12(9): e0184709. Doi: 10.1371/ journal.pone.0184709.  Back to cited text no. 46
    
47.
Kou X, Li B, Olayanju JB, Drake JM, Chen N. Nutraceutical or pharmacological potential of Moringa oleifera Lam. Nutrients 2018; 10(3). pii: E343. Doi: 10.3390/nu10030343.  Back to cited text no. 47
    
48.
Jaja-Chimedza A, Graf BL, Simmler C, Kim Y, Kuhn P, Pauli GF, et al. Biochemical characterization and anti-inflammatory properties of an isothiocyanate-enriched moringa (Moringa oleifera) seed extract. PLoS One 2017; 12(8): e0182658. Doi: 10.1371/journal.pone.0182658.  Back to cited text no. 48
    
49.
Yu CW, Li WH, Hsu FL, Yen PL, Chang ST, Liao VH. Essential oil alloaromadendrene from mixed-type Cinnamomum osmophloeum leaves prolongs the life span in Caenorhabditis elegans. J Agric Food Chem 2014; 62(26): 6159-6165. Doi: 10.1021/jf500417y.  Back to cited text no. 49
    
50.
Hu JJ, Wang H, Pan CW, Lin MX. Isovitexin alleviates liver injury induced by lipopolysaccharide/d-galactosamine by activating Nrf2 and inhibiting NF-κB activation. Microb Pathog 2018; 119: 86-92. Doi: 10.1016/j.micpath.2018.03.053.  Back to cited text no. 50
    
51.
Omodanisi EI, Aboua YG, Oguntibeju OO. Assessment of the anti-hyperglycaemic, anti-inflammatory and antioxidant activities of the methanol extract of Moringa oleifera in diabetes-induced nephrotoxic male Wistar rats. Molecules 2017; 22(4): E439. Doi: 10.3390/ molecules22040439.  Back to cited text no. 51
    
52.
Al-Dabbas MM. Antioxidant activity of different extracts from the aerial part of Moringa peregrina (Forssk.) Fiori, from Jordan. Pak J Pharm Sci 2017; 30(6): 2151-2157.  Back to cited text no. 52
    
53.
Fitriana WD, Ersam T, Shimizu K, Fatmawati S. Antioxidant activity of Moringa oleifera extracts. Indones J Chem 2016; 16(3): 297-301. Doi: 10.22146/ijc.21145.  Back to cited text no. 53
    
54.
Tan WS, Arulselvan P, Karthivashan G, Fakurazi S. Moringa oleifera flower extract suppresses the activation of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 macrophages via NF-κB pathway. Mediators Inflamm 2015; 2015: 720171. Doi: 10.1155/2015/720171.  Back to cited text no. 54
    
55.
Paikra BK, Dhongade HKJ, Gidwani B. Phytochemistry and pharmacology of Moringa oleifera Lam. J Pharmacopuncture 2017; 20(3): 194-200. Doi: 10.3831/KPI.2017.20.022.  Back to cited text no. 55
    
56.
Dos Santos AO, do Val DR, da Silveira FD, Gomes FIF, Freitas HC, de Assis EL, et al. Antinociceptive, anti-inflammatory and toxicological evaluation of semi-synthetic molecules obtained from a benzyl-isothiocyanate isolated from Moringa oleifera Lam. in a temporomandibular joint inflammatory hypernociception model in rats. Biomed Pharmacother 2018; 98: 609-618. Doi: 10.1016/ j.biopha.2017.12.102.  Back to cited text no. 56
    
57.
Nfambi J, Bbosa GS, Sembajwe LF, Gakunga J, Kasolo JN. Immunomodulatory activity of methanolic leaf extract of Moringa oleifera in Wistar albino rats. J Basic Clin Physiol Pharmacol 2015; 26(6): 603-611. Doi: 10.1515/jbcpp-2014-0104.  Back to cited text no. 57
    
58.
Attia YA, Al-Khalaifah H, Ibrahim MS, Al-Hamid AEA, Al-Harthi MA, El-Naggar A. Blood hematological and biochemical constituents, antioxidant enzymes, immunity and lymphoid organs of broiler chicks supplemented with propolis, bee pollen and mannan oligosaccharides continuously or intermittently. Poult Sci 2017; 96(12): 4182-4192. Doi:10.3382/ps/pex173.  Back to cited text no. 58
    
59.
Oliveira-Tintino CDM, Pessoa RT, Fernandes MNM, Alcântara IS, da Silva BAF, de Oliveira MRC, et al. Anti-inflammatory and anti-edematogenic action of the Croton campestris A. St.-Hil (Euphorbiaceae) essential oil and the compound β -caryophyllene in in vivo models. Phytomedicine 2018; 41: 82-95. Doi: 10.1016/j.phymed.2018.02.004.  Back to cited text no. 59
    
60.
Elnakady YA, Rushdi AI, Franke R, Abutaha N, Ebaid H, Baabbad M, et al. Characteristics, chemical compositions and biological activities of propolis from Al-Bahah, Saudi Arabia. Sci Rep 2017; 6(7): 41453. Doi: 10.1038/srep41453.  Back to cited text no. 60
    
61.
Wang K, Ping S, Huang S, Hu L, Xuan H, Zhang C, et al. Molecular mechanisms underlying the in vitro anti-inflammatory effects of a flavonoid-rich ethanol extract from Chinese propolis. poplar type. Evid Based Complement Alternat Med 2013; 2013: 127672. Doi: 10.1155/2013/127672.  Back to cited text no. 61
    
62.
Wang K, Zhang J, Ping S, Ma Q, Chen X, Xuan H, et al. Anti-inflammatory effects of ethanol extracts of Chinese propolis and buds from poplar (Populus×canadensis). J Ethnopharmacol 2014; 155(1): 300-311. Doi: 10.1016/j.jep.2014.05.037.  Back to cited text no. 62
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  2. Materials and...
  In this article
Abstract
1. Introduction
3. Results
4. Discussion
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed543    
    Printed35    
    Emailed0    
    PDF Downloaded219    
    Comments [Add]    

Recommend this journal